Back

Estimating Direct and Spillover Vaccine Effectiveness with Partial Interference under Test-Negative Design Sampling

Jiang, C.; Fang, F.; Talbot, D.; Schnitzer, M.

2025-02-25 infectious diseases
10.1101/2025.02.24.25322826 medRxiv
Show abstract

The Test-Negative Design (TND), which involves recruiting care-seeking individuals who meet predefined clinical case criteria, offers valid statistical inference for Vaccine Effectiveness (VE) using data collected through passive surveillance, making it cost-efficient and timely. Infectious disease epidemiology often involves interference, where the treatment and/or outcome of one individual can affect the outcomes of others, rendering standard causal estimands ill-defined; ignoring such interference can bias VE evaluation and lead to ineffective vaccination policies. This article addresses the estimation of causal estimands for VE in the presence of partial interference using TND samples. Partial interference means that the vaccination of units within the same group/cluster may influence the outcomes of other members of the cluster. We define the population direct, spillover, total, and overall effects using the geometric risk ratio, which are identifiable under TND sampling. We investigate various stochastic policies for vaccine allocation in a counterfactual scenario, and identify policy-relevant VE causal estimands. We propose inverse-probability weighted (IPW) estimators for estimating the policy-relevant VE causal estimands with partial interference under the TND, and explore the statistical properties of these estimators.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Statistics in Medicine
34 papers in training set
Top 0.1%
14.4%
2
Biometrics
22 papers in training set
Top 0.1%
10.4%
3
PLOS Computational Biology
1633 papers in training set
Top 5%
6.8%
4
PLOS ONE
4510 papers in training set
Top 32%
4.9%
5
Journal of The Royal Society Interface
189 papers in training set
Top 0.9%
4.3%
6
Epidemics
104 papers in training set
Top 0.4%
4.0%
7
Nature Computational Science
50 papers in training set
Top 0.1%
3.6%
8
Clinical Infectious Diseases
231 papers in training set
Top 2%
3.3%
50% of probability mass above
9
Nature Communications
4913 papers in training set
Top 42%
3.3%
10
Emerging Infectious Diseases
103 papers in training set
Top 0.7%
3.1%
11
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.4%
12
Scientific Reports
3102 papers in training set
Top 50%
2.1%
13
Mathematical Biosciences and Engineering
23 papers in training set
Top 0.2%
1.9%
14
Bulletin of Mathematical Biology
84 papers in training set
Top 0.9%
1.9%
15
Biostatistics
21 papers in training set
Top 0.1%
1.9%
16
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 31%
1.8%
17
Infectious Disease Modelling
50 papers in training set
Top 0.8%
1.7%
18
Epidemiology
26 papers in training set
Top 0.3%
1.7%
19
Epidemiology and Infection
84 papers in training set
Top 2%
1.3%
20
Science Advances
1098 papers in training set
Top 21%
1.3%
21
Medical Decision Making
10 papers in training set
Top 0.2%
1.1%
22
Journal of Theoretical Biology
144 papers in training set
Top 1%
0.9%
23
PNAS Nexus
147 papers in training set
Top 1%
0.8%
24
Philosophical Transactions of the Royal Society A: Mathematical, Physical and Engineering Sciences
12 papers in training set
Top 0.1%
0.8%
25
International Journal of Epidemiology
74 papers in training set
Top 2%
0.8%
26
Vaccine
189 papers in training set
Top 2%
0.8%
27
eLife
5422 papers in training set
Top 55%
0.8%
28
Science
429 papers in training set
Top 19%
0.7%
29
Royal Society Open Science
193 papers in training set
Top 5%
0.7%
30
International Journal of Infectious Diseases
126 papers in training set
Top 4%
0.7%